Case report: a thiazide diuretic to treat polyuria induced by tolvaptan

Currently, the vasopressin V2 receptor antagonist tolvaptan is the only available treatment for autosomal dominant polycystic kidney disease (ADPKD), but there are tolerability issues due to aquaretic side-eff...

Source: BMC Nephrology - July 3, 2018 Category: Urology & Nephrology Authors: Bart J. Kramers, Maatje D. A. van Gastel, Esther Meijer and Ron T. Gansevoort Tags: Case report Source Type: research